UAE Heart Failure Treatment Devices Market Research Report: Forecast (2025-2030)

Market Definition

Heart Failure Treatment Devices including implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy (CRT), and others are medical devices for treating and managing patients with advanced heart failure. These devices have been significantly improving the lives of patients as well as reducing death rates from heart failure & sudden cardiac arrest.

Market Insights & Analysis: The UAE Heart Failure Treatment Devices Market (2025-30):

The UAE Heart Failure Treatment Devices Market size was valued at around USD 221.85 million in 2024 and is projected to reach USD 442.97 million by 2030. The market is also estimated to grow at a CAGR of around 12% during the forecast period, i.e., 2025-30.

In the country, obesity levels have been soaring consistently. This is primarily driven by changes in cultural & social environments, unhealthy and improper diet and nutrition, lack of involvement in physical activities, the issue of binge eating disorder, especially among youths, etc. Obesity has been one of the leading causes behind elevating the risk for cardiovascular diseases (CVDs) as per the 2024 Fact by the World Health Organization (WHO). In the UAE as well, this has been contributing to the increased number of cases of CVDs like heart failure. Therefore, the market for heart failure treatment devices has expanded in the UAE, with positive growth trends. For instance, obesity prevalence as the UAE government mentioned in 2023 was around 27.8% of the total population. Also, 7.5 million people including adults, children, and adolescents as stated by the World Obesity Federation, 2035, will be living with overweight and obesity in the UAE.

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Also, in many emirates, patients with hypertension have been increasing at concerning rates. This has been due to stress, obesity, & elevating diabetes rates in the country. The CDC fact even mentions that health conditions like diabetes & obesity tend to increase the possibility of high blood pressure. Hence, as the rates of these conditions like obesity & diabetes have been surging in the country subsequent rise has been there in the cases of hypertension. For instance, in the UAE, around 990,900 adults aged between 20 and 79 years were affected by diabetes, and the cases are expected to increase to about 1,177,500 by 2030. Likewise, heart failure cases because of hypertension and diabetes which tend to increase the risk of developing heart failure by >2x as pointed out by the American Heart Association have been reported in the country, subsequently raising the demand for devices like ICD & CRT.

Moreover, heart transplantation rates have been low in the country because of a shortage of donors. This has led healthcare providers in the nation to highly depend upon devices like impella & LVAD which are crucial for patients to the point they receive heart transplants.

Additionally, in the UAE, there has been a strong presence of major key players like Medtronic & Abbott that through their distributors have been ensuring the availability of advanced heart failure treatment technologies like ICD, CRT, etc. to the healthcare facilities in the UAE without compromising the patient's condition.

The UAE Heart Failure Treatment Devices Market Driver:

Heightened Prevalence of Cardiovascular Diseases & Heart Failure  – In Dubai, Sharjah, Abu Dhabi & Ain, and others, due to factors such as obesity, hypertension, diabetes, etc., the rates of cardiovascular diseases (CVDs) and heart failure have been alarming. For instance, as per the Institute for Health Metrics and Evaluation, the number of cases of cardiovascular diseases increased from 621,314 in 2019 to more than 800,000 in 2024.

Also, the conditions have been responsible for huge mortality rates in the country as evidenced by the United Nations data that states that cardiovascular diseases (CVD) are responsible for causing 34% of all deaths in the UAE.  Subsequently, to treat and manage patients with heart failure and other CVDs like arrhythmia as well as to reduce the heightened mortality & morbidity rates due to these disease conditions in the country, the demand for devices like ICD, CRT, heart pumps, etc. has been increasing. As a result, the market size for the UAE Heart Failure Treatment Devices has been expanding.

The UAE Heart Failure Treatment Devices Market Challenge:

The Challenge of Undiagnosed & Underrepresented Heart Failure Cases & High Cost of Devices in the UAE – There have been significant gaps in the actual prevalent cases of heart failure and recorded or reported ones in the UAE. This is because a majority of UAE residents do not undergo heart health evaluations despite being aware of heart failure and its risk factors like obesity & diabetes. Similar scenarios have been there where individuals have not gone for blood pressure testing, potentially leading to an undiagnosed population. Due to such cases, the diagnostic and treatment population that requires such devices for an improved quality of life has been low, negatively impacting the growth of the overall market.

Also, the cost of heart failure treatment devices has been high ranging from USD30,000 to USD80,000 or more due to devices being imported from the US, and Europe because of limited manufacturing in the country, taxes, advanced tehnologies, etc. As a result, expatriates who formed around 88% of the country’s total population in 2023, and those majorly affected by such diseases receive treatments elsewhere. Subsequently, the market has been adversely affected.

The UAE Heart Failure Treatment Devices Market Trend:

Development of Combination Devices & Remote Monitoring Features Enhancing Device Acceptability – In recent years, hospitalization rates due to heart failure have been on the rise in the UAE. Also, heart failure readmission rates exceed those of other medical and surgical conditions. The country’s healthcare system and economy too have been under a significant financial burden due to this, thereby underscoring the urgent need for technology-advanced and improved devices for treating & managing heart failure. Moreover, patients too have been reluctant to stay in hospitals for a longer period which not only proves them costly but causes an increased risk of hospital-acquired infections, ultimately deteriorating the overall condition.

Realizing the need, companies like Abbott, Medtronic, Biotronik, and others have been developing and offering ICD & CRT devices that have improved features like remote monitoring or combo devices that have both a pacemaker and an ICD function. For example, Medtronic offers Cobalt™ HF CRT-Ds that have both ICD & pacemaker functions along with remote monitoring capabilities. Moreover, healthcare facilities & providers in the UAE too have been showing keen interest in such technologies causing them to incorporate such devices in their practice. For instance, in 2022, RAK Hospital mentioned using innovative cardiac resynchronization therapy with Defibrillator (CRT-D) or combo device for the first time to save a patient’s life who was on the verge of heart failure. In the coming years, as more companies invest in newer heart failure technologies or advancements, the market would register positive growth trends.

The UAE Heart Failure Treatment Devices Market (2025-30): Segmentation Analysis

The UAE Heart Failure Treatment Devices Market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for 2025–2030 at the national level. Based on the analysis, the market has been further classified as:

Based on Product Type:

• Implantable Cardioverter-Defibrillator (ICD)
• Cardiac Resynchronization Therapy (CRT)
  • Cardiac Resynchronization Therapy Pacemaker (CRT- P)
  • Cardiac Resynchronization Therapy Defibrillator (CRT- D)
• Others

The Implantable Cardioverter-Defibrillator (ICD) held the largest market share of the overall UAE Heart Failure Treatment Devices Market. This owes to the concerning rates of heart failure and arrhythmias in the country where device implantation becomes necessary to prevent the sudden cardiac death (SCD) of the patients. More importantly, as the condition of sudden cardiac death (SCD) or sudden cardiac arrest has been a leading cause of thousands of deaths in the country each year, the usage of the device has seen a significant boost. Eventually, the segment’s market has been growing in the UAE.

Further, cases of congenital heart defects (CHD) have been in notable numbers in the country. The condition could lead to heart failure in children, and those who survive face complications in adulthood. As advances in ICD help correct life-threatening irregular heartbeats and reduce mortality from CHD, the demand for it has been increasing in the UAE. Hence, the category’s market size has been expanding and would continue to grow in the coming years as well. For instance, as stated by the UAE Congenital Heart Association, each year approximately 970 children are born with congenital heart disease in the UAE.

Based on End User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

Among all the different types of end users, the largest market share has been held by the hospitals. This is because hospitals are the major healthcare facilities in the UAE that cater to a large number of patients with heart failure. Subsequently, these hospitals generate more demand for ICD, CRT, and other heart failure treatment devices than other end users. Further, in recent years, with goals to improve the healthcare infrastructure of the country, the UAE government has been investing in the construction of newer hospitals as well as the expansion of existing ones with cardiology being one of the major specialties in these hospitals. This is expected to create opportunistic demand for many heart failure treatment devices in the country.

Moreover, private hospitals too have been equally investing in their facilities as medical tourism is growing in the country and patients from different regions like Asia, Europe, etc. have been visiting them to get high-class treatments for diseases like heart failure. Hence, as a result of the aforementioned factors, the hospital’s category would be registering growth in the coming years as well.

Gain a Competitive Edge with Our The UAE Heart Failure Treatment Devices Market Report

1. The UAE Heart Failure Treatment Devices Market by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
2. This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
3. The UAE Heart Failure Treatment Devices Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.